CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Total revenues		$ 32,681	$ 38,666	$ 112,649	$ 118,306
Total costs of revenues		15,058	21,640	52,374	66,366
Gross profit		17,623	17,026	60,275	51,940
Operating expenses:
Sales and marketing		2,745	4,648	9,785	11,621
Research and development		1,978	2,175	4,111	5,944
General and administrative		8,817	12,628	32,591	36,975
Depreciation and amortization		1,828	3,336	5,175	13,272
Stock-based compensation		598	2,126	2,645	4,588
Impairment of goodwill, intangible assets, and other long-lived assets		41,217	106,096	49,958	112,345
Acquisition, integration, and transformation costs		33,229	6,049	40,319	15,182
Total operating expenses		90,412	137,058	144,584	199,927
Loss from operations		(72,789)	(120,032)	(84,309)	(147,987)
Other income (expense):
Interest expense		(6,709)	(6,708)	(20,703)	(20,306)
Gain (loss) on deconsolidation of subsidiary		59,065	(37,708)	59,065	(37,708)
Gain (loss) on fair value of derivative liability		0	223	(3)	6,893
Loss on extinguishment of debt		0	(14,610)	0	(14,610)
Other income, net, including interest income		295	32	425	220
Total other income (expense)		52,651	(58,771)	38,784	(65,511)
Loss before income tax benefit (expense)		(20,138)	(178,803)	(45,525)	(213,498)
Income tax benefit (expense)		0	13,219	(867)	17,744
Net loss		(20,138)	(165,584)	(46,392)	(195,754)
Less: net income (loss) attributable to noncontrolling interests		467	178	1,423	(109)
Net loss attributable to UpHealth, Inc.		$ (20,605)	$ (165,762)	$ (47,815)	$ (195,645)
Net loss per share attributable to UpHealth, Inc.:
Basic (in dollars per share)		$ (1.12)	$ (11.17)	$ (2.74)	$ (13.41)
Diluted (in dollars per share)		$ (1.12)	$ (11.17)	$ (2.74)	$ (13.41)
Weighted average shares outstanding:
Basic (in shares)	[1]	18,428	14,842	17,459	14,588
Diluted (in shares)	[1]	18,428	14,842	17,459	14,588
Services
Total revenues		$ 30,825	$ 27,600	$ 92,853	$ 81,382
Total costs of revenues		14,493	14,913	43,191	46,903
Licenses and subscriptions
Total revenues		1,760	2,019	6,548	10,612
Total costs of revenues		425	463	1,147	913
Products
Total revenues		96	9,047	13,248	26,312
Total costs of revenues		$ 140	$ 6,264	$ 8,036	$ 18,550

[1] Amounts as of September 30, 2022 and before that date differ from those published in our prior condensed consolidated financial statements as they were retrospectively adjusted as a result of the Reverse Stock Split (as described below in Note 1. Organization and Business). Specifically, the number of common shares outstanding during periods before the Reverse Stock Split are divided by the exchange ratio of 10:1, such that each ten shares of common stock were combined and reconstituted into one share of common stock effective December 8, 2022.